Biotech Daily — Dr Boreham’s Crucible: 4DMedical
“4D’s patented XV Technology platform enables doctors to understand ‘regional’ airflow in
the lungs, thus identifying illnesses with greater efficacy as patients breathe.”
Patient Story – Bronchiectasis
John was diagnosed with bronchiectasis at age 14. Bronchiectasis is commonly defined as a condition where damage to the lungs causes the airways to widen or develop pouches which makes it more challenging to clear out mucus, leading to frequent infections. This differs from the more common condition of bronchitis, which is a temporary illness and causes no long-term damage. According to the American Lung Association, Bronchiectasis affects 350,000 to 500,000 people in the United States.